InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
6
T+90 hit rate
75%
T+90 mean return
-3.7%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by SPIEGELMAN DANIEL K, Director. Insider active across 1 company, notably Myriad Genetics INC. Cumulatively, 12 filings have been logged. Breakdown: 0 buy · 6 sells. Total volume traded: €693k. Activity tracked since 27 May 2021. The latest transaction was disclosed on 3 June 2024 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations12 total
3,788 shares@ US$22.0411.1% of flowCommon StockSEC:0001238403-24-000002:0
15,151 shares0Common StockSEC:0001238403-23-000002:0
6,424 shares@ US$19.25170.034% mcap18.8% of flowCommon StockSEC:0001238403-22-000002:0
17,275 shares0Common StockSEC:0001628280-22-016223:0
3,139 shares@ US$30.517611.6% of flowCommon StockSEC:0001238403-21-000008
3,139 shares@ US$30.51760.024% mcap13.1% of flowCommon StockSEC:0001238403-21-000008:0
12,848 shares0Common StockSEC:0001238403-21-000006:0
12,848 shares0Common StockSEC:0001238403-21-000006
7,142 shares@ US$28.986727.6% of flowCommon StockSEC:0001238403-21-000004
7,142 shares@ US$28.98670.050% mcap27.6% of flowCommon StockSEC:0001238403-21-000004:0
15,889 shares0Common StockSEC:0001238403-21-000002:0
15,889 shares0Common StockSEC:0001238403-21-000002
12 of 12 declarations
About SPIEGELMAN DANIEL K
Daniel K. Spiegelman is a Board Member at Myriad Genetics Inc. As a board member, he contributes to the governance of the company and strategic decision-making. His experience in the biotechnology sector allows him to provide valuable insights for the company's development. Daniel Spiegelman plays a key role in evaluating performance and growth opportunities.
